Hostname: page-component-7c8c6479df-94d59 Total loading time: 0 Render date: 2024-03-28T08:04:14.899Z Has data issue: false hasContentIssue false

Postcards from the EDge: 24-month outcomes of a randomised controlled trial for hospital-treated self-poisoning

Published online by Cambridge University Press:  02 January 2018

Gregory L. Carter*
Affiliation:
Suicide Prevention Research Unit, Centre for Mental Health Studies, Faculty of Health, University of Newcastle, New South Wales, and Department of Consultation–Liaison Psychiatry, Newcastle Mater Hospital, Newcastle
Kerrie Clover
Affiliation:
Suicide Prevention Research Unit, Centre for Mental Health Studies, and Faculty of Health, University of Newcastle
Ian M. Whyte
Affiliation:
Discipline of Clinical Pharmacology, Faculty of Health, University of Newcastle, and Department of Clinical Toxicology and Pharmacology Newcastle Mater Hospital, Newcastle
Andrew H. Dawson
Affiliation:
Discipline of Clinical Pharmacology, Faculty of Health, University of Newcastle, Australia, and South Asian Clinical Toxicology Research Collaboration University of Peradeniya, Sri Lanka
Catherine D'Este
Affiliation:
Centre for Clinical Epidemiology and Biostatistics, Faculty of Health, University of Newcastle, and Centre for Military and Veterans' Health, University of Queensland, Brisbane, Australia
*
Dr Gregory Carter, Department of Consultation–Liaison Psychiatry, Locked Bag 7, Hunter Region Mail Centre, NSW 2310, Australia. Tel: + 612 4921 1283; fax: + 612 4921 1870; email: Gregory.Carter@newcastle.edu.au
Rights & Permissions [Opens in a new window]

Abstract

Background

Repetition of self-poisoning is common.

Aims

To report the 24-month outcomes of a non-obligatory postcard intervention (plus treatment as usual) compared with treatment as usual.

Method

In a randomised-controlled trial (Zelen design) conducted in Newcastle, Australia, eight postcards were sent to participants over a 12-month period. The principal outcomes were the proportion of participants with one or more repeat episodes of self-poisoning and the number of repeat episodes per person.

Results

No significant reduction was observed in the proportion of people repeating self-poisoning in the intervention group (21.2%, 95% CI 17.0–25.3) compared with the control group (22.8%, 95% CI 18.7–27.0; χ2=0.32, d.f. = 1, P= 0.57); the difference between groups was −1.7% (95% CI −7.5 to 4.2). There was a significant reduction in the rate of repetition, with an incidence risk ratio of 0.49 (95% CI 0.33–0.73).

Conclusions

A postcard intervention maintained the halving of the rate of repetition of hospital-treated self-poisoning events over a 2-year period, although it did not significantly reduce the proportion of individuals who repeated self-poisoning.

Type
Papers
Copyright
Copyright © Royal College of Psychiatrists, 2007 

Hospital-treated self-poisoning is common in Australia (Reference McGrathMcGrath, 1989). Self-harm is common in the UK (Reference House, Owens and PatchettHouse et al, 1998), with self-poisoning being the most common form and with most patients making their initial contact with hospital through the emergency department (Reference Gunnell, Bennewith and PetersGunnell et al, 2005). Repetition of self-harm within 12 months of an index episode is common, with a median rate of 16% (interquartile range 12–25%), has a strong association with subsequent suicide and has significant resource implications for the health system (Reference Owens, Horrocks and HouseOwens et al, 2002). Five non-pharmacological interventions have been shown to be effective in reducing repetition of self-harm: one after 6 months' follow-up (Reference Guthrie, Kapur and Mackway-JonesGuthrie et al, 2001), three at the completion of the intervention duration of 12 months (Reference Linehan, Armstrong and SuarezLinehan et al, 1991; Reference Brown, Ten Have and HenriquesBrown et al, 2005; Reference Carter, Clover and WhyteCarter et al, 2005); and one at treatment completion after 18 months (Reference Bateman and FonagyBateman & Fonagy, 1999). Only three studies have reported sustained, beneficial repetition outcomes beyond the intervention duration: one reported outcomes after 6 months (Reference Guthrie, Kapur and Mackway-JonesGuthrie et al, 2001), one after 36 months (18 months' follow-up; Reference Bateman and FonagyBateman & Fonagy, 2001) and one after 24 months (12 months' follow-up; Reference Linehan, Comtois and MurrayLinehan et al, 2006). We have previously shown that a postcard intervention reduced the rate of repetition of hospital-treated self-poisoning events over the 12-month period of the intervention (Reference Carter, Clover and WhyteCarter et al, 2005). In this paper we report on the 24-month outcomes. There were two primary outcomes: the proportion of patients with at least one further episode; and the number of further admissions for self-poisoning per individual.

METHOD

The study methods have been previously reported in detail (Reference Carter, Clover and WhyteCarter et al, 2005).

Setting

The Hunter Area Toxicology Service (HATS) is a regional toxicology unit at the Newcastle Mater Misericordiae Hospital, New South Wales, Australia, serving a primary referral population of 385 000 adults and a tertiary referral population of a further 170 000. All poisoning presentations to emergency departments in the greater Newcastle region are either admitted to HATS or notified to HATS and entered prospectively into a clinical database (Whyte et al, Reference Whyte, Dawson and Buckley1997, Reference Whyte, Buckley and Dawson2002). The HATS model of service delivery means that in (virtually) all cases of self-poisoning in the catchment area the person is brought to the Newcastle Mater Hospital for treatment and in all cases the person is formally admitted under the care of HATS. The psychiatry department sees all such patients for assessment and diagnosis, and to determine discharge destination and follow-up. Details of the model of service for these patients have been described by Whyte et al (Reference Whyte, Dawson and Buckley1997).

Study population

Patients aged 16 years or over who presented to HATS during the recruitment period (April 1998 to December 2001) were potentially eligible. Inclusion criteria were that the patient must be capable of informed consent, not considered to pose a threat to an interviewer, not of ‘no fixed address’ and with sufficient English to complete a structured interview.

Variables

The two dependent variables were the proportion of individuals who had one or more readmissions for self-poisoning and the number of readmissions for self-poisoning per individual, over 24 months. Descriptive variables were obtained from the standardised clinical assessment of the patients (Reference Buckley, Whyte and DawsonBuckley et al, 1999) and extracted from the HATS database. The categorical variables were gender, marital status (married, including de facto relationships, v. never married, separated, divorced or widowed), employment (full-time or part-time v. unemployed, pensioner, student or other), intensive care unit admission, time of admission (09.00–17.00 weekdays v. out of hours) and discharge destination (psychiatric hospital v. all others). The continuous variables were age, length of stay in hours, median number of previous admissions to HATS for self-poisoning and number of psychiatric diagnoses from clinical assessment.

Study design

A randomised consent (Zelen: single consent version) design was used (Zelen, Reference Zelen1979, Reference Zelen1990). This design is a variation on the standard randomised controlled experimental design, in which participants were randomised to control or intervention before consent was sought. In the single consent version, written informed consent to receive the intervention (eight non-obligatory postcards) was sought only from participants randomised to the intervention. The outcomes were assessed by an intention-to-treat analysis based on randomisation status.

The Hunter Area Health Research Ethics Committee approved this study, including the randomised consent design.

Randomisation

Randomisation was by database (HanD-Base version 2.0; DDH Software, Wellington, Florida, USA) on a personal digital assistant (Palm III; Palm, Inc., Sunnyvale, California, USA) which was populated with a pre-generated randomisation schedule (in blocks of ten) and carried by the duty toxicologist. To avoid recruiting patients more than once, identification information was searched in this database before enrolment. To maintain masking to allocation status during recruitment, randomisation was not revealed until after all information was entered and eligibility determined. Randomisation status was then revealed in order to obtain patient consent. To monitor any potential alterations (interference) a duplicate record was kept in a hidden field of the database and a copy held on a separate computer for later verification of correct randomisation status.

All other clinical and research staff were unaware of allocation.

Intervention

A new intervention was developed based on the study by Jerome Motto, which demonstrated reduced death by suicide in a psychiatric hospital in-patient population (Reference MottoMotto, 1976; Reference Motto and BostromMotto & Bostrom, 2001). The new intervention was a series of eight ‘postcards’ sent in a sealed envelope in months 1, 2, 3, 4, 6, 8, 10 and 12 after discharge (the postcard is shown in the online supplement to this paper). All participants received treatment as usual.

Sample size

During study planning several sample sizes were calculated based on different estimates of possible effects for the 12-month outcomes (Reference Carter, Clover and FryerCarter et al, 1999). A difference in proportions (5% significance level, 80% power) of 15% to 10% required 1364 participants, 20% to 10% required 392 participants and 30% to 20% required 293 participants. On the basis of clinical experience and previous research it was anticipated that 15–30% of the control group would self-poison again within 12 months, with an average of two episodes, meaning overall self-poisoning rates of 30–60%. A sample of 400 per group would allow detection of absolute differences between groups of 10–15% (5% significance level, 80% power) and 12–17% (5% significance level, 90% power), yielding relative risks of 0.67–0.75 and 0.60–0.72 (80% and 90% power respectively). This sample size would be adequate to detect differences in the proportion of participants who had any episode of self-poisoning of 7–9% (80% power) and 8–10% (90% power and 5% significance level), which we considered would represent a clinically significant reduction.

Statistical analyses

Data were analysed using the computerised statistical packages SPSS version 10.0 and Intercooled Stata versions 7 and 8. The difference in proportions of participants with any readmission for self-poisoning was tested with χ2 analyses. For the number of readmissions per individual, a negative binomial regression was undertaken to compare the risk of self-poisoning events per individual in the postcard group relative to the control group and is reported as incidence risk ratio (IRR) with 95% confidence intervals. Two subgroup analyses, using negative binomial models, were undertaken for the treatment effect for male and female groups, since a post hoc analysis of 12-month outcomes suggested a gender effect (Reference Carter, Clover and WhyteCarter et al, 2005).

Intent to treat

We assessed 922 patients for eligibility, of whom 150 (16%) were ineligible (Fig. 1), leaving 772 potential participants (control group n=394 intervention group n=378). Among the intervention group, 76 refused the intervention, 1 missed the intervention as planned and 32 did not receive the full intervention (this was due to these people being unavailable, their postcards being returned ‘not known at this address - return to sender’). Twenty people in the control group received the intervention owing to clerical errors, but were retained in the control group as data were analysed as intention to treat, based on randomisation.

Fig. 1 Study profile (TAU, treatment as usual).

RESULTS

The characteristics of the sample at baseline are summarised in Table 1. Previous episodes of hospital-treated self-poisoning were recorded for 17% of the total sample, (129/772), 17% of the control group (66/394) and 17% of the intervention group (63/378). The frequency of the poisoning subtypes were: pharmaceuticals only, 473 (61%); pharmaceuticals plus alcohol, 217 (28%); opioid or amphetamine, 20 (3%); carbon monoxide, 17 (2%); herbicide or rodenticide, 11 (1%); insulin, 7 (1%); self-poisoning with additional self-harm 23 (3%); and unknown poison, 4 (1%).

Table 1 Characteristics of the study sample

Missing data n Total sample (n=772) Control group (n=394) Intervention group (n=378)
Categorical variables, n (%)
   Female 1 524 (68) 291 (74) 233 (62)
   Married 1 31 256 (35) 118 (31) 138 (38)
   Employed 153 162 (26) 88 (27) 74 (26)
   Admitted to intensive care 0 113 (15) 60 (15) 53 (14)
   Admitted outside office hours 0 581 (75) 296 (75) 285 (75)
   Discharged to psychiatric hospital 2 208 (27) 106 (27) 102 (27)
   Previous admission for self-poisoning 0 129 (17) 66 (17) 63 (17)
Continuous variables, median (Q1–Q3) 2
   Age, years 0 33 (24–44) 34 (23–45) 33 (24–42)
   Length of stay, h 0 18 (12–30) 18 (13–31) 17 (12–29)
   Number of prior self-poisoning admissions 0 0 0 0
   Number of psychiatric diagnoses 0 2 (1–2) 2 (1–3) 2 (1–3)

1. Includes de facto relationships

2. First quartile–third quartile

Proportion of sample repeating self-poisoning

In the intervention group 21.2% (80/378; 95% CI 17.0–25.3) had one or more readmissions for self-poisoning compared with 22.8% (90/394; 95% CI 18.7–27.0) in the control group 24 months after baseline, a non-significant difference (χ2=0.317, d.f.=1, P=0.57), the difference between groups being −1.7% (95% CI −7.5 to 4.2).

Number of repeat admissions

There were 310 cumulative readmissions in the control group and 145 in the intervention group (Fig. 2). Table 2 shows the relative risks for the intervention group compared with the control group from the negative binomial regressions. The risk of repetition was statistically significantly lower in the intervention group (IRR=0.49, 0.49, 95% CI 0.33–0.73). Separate subgroup analyses by gender showed the treatment was effective for women (IRR=0.49, 95% CI 0.30–0.80) but not for men (IRR=0.97, 95% CI 0.50–1.88. Readmissions by intervention group and gender are shown in Table 3.

Fig. 2 Cumulative readmissions to hospital for treatment of self-poisoning (24 months; unadjusted for multiple admissions).

Table 2 Negative binomial models for 24-month outcomes for intervention effect on number of readmissions for self-poisoning and for subgroup analyses by gender

Incidence risk ratio Wald test
IRR s.e. 95% CI Z P
Whole sample, unadjusted (n=772)
   Control 1.00
   Intervention 0.49 0.10 0.33–0.73 –3.51 0.010
Men (n=247)
   Control 1 1.00
   Intervention 0.97 0.33 0.50–1.88 –0.09 0.929
Women (n=524)
   Control 1 1.00
   Intervention 0.49 0.12 0.30–0.80 –2.87 0.004

1. One control group participant with missing data for gender (13 readmissions) is not included in either gender subgroup analysis

Table 3 Number of repetitions of self-poisoning by gender and experimental group

Number of repetitions Control group (n=394) 1 Intervention group (n=378)
Men (n=102) Women (n=291) Men (n=145) Women (n=233)
n (%) Total repetitions n (%) Total repetitions n (%) Total repetitions n (%) Total repetitions
None 83 (81) 0 221 (76) 0 119 (82) 0 179 (77) 0
One 14 (14) 14 34 (12) 34 19 (13) 19 32 (14) 32
Two 3 (3) 6 12 (4) 24 4 (3) 8 14 (6) 28
Three or more 2 (2) 9 24 (8) 210 3 (2) 13 8 (3) 45

1. One control group participant with missing data for gender had 13 readmissions

DISCUSSION

Strengths and weaknesses of the study

This study had several strengths. First, a randomised consent design was used, which was suited to this study and this clinical population. In this study the baseline characteristics and principal outcomes were tracked by the HATS database, allowing for complete follow-up. Second, the quality of the randomisation was strong, with randomisation undertaken using a handheld personal computer device in combination with another computer which could detect any errors of allocation status and interference with the randomisation. Third, all participants, clinicians and research staff were masked to the primary outcome measurement; only the recruiting toxicologists and the secretary responsible for managing the mailing database and postcards were aware of allocation status. Owing to the randomised design, the quality of masking to allocation and to outcome, and the service model of HATS in which all cases of self-poisoning are admitted to hospital, we believe that there are few threats to internal validity in this study.

There were some limitations to consider for this study and caution needs to be used when interpreting the results. Less than a quarter of the participants self-poisoned a second time, and a subgroup showed a highly skewed pattern of more than one repeat episode. It is not known to what extent the HATS referral population and model of clinical service (Reference Whyte, Dawson and BuckleyWhyte et al, 1997) would be generalisable to other settings. This study investigated patients who self-poisoned and the results cannot necessarily be generalised to patients with other forms of self-harm. We do not currently have data available on mortality and suicide outcomes for the study participants. A previous longitudinal study in our centre found a 1% suicide rate after 24 months and nearly 2% suicide rate after 5 years, which would translate to 8 suicide deaths and 16 suicide deaths respectively (Reference Reith, Whyte and CarterReith et al, 2004). These suicide rates are lower than the 12-month 1.8% rate reported in a recent meta-analysis of psychosocial interventions after self-harm (Reference Crawford, Thomas and KhanCrawford et al, 2007). We intend to be able to report the mortality and suicide outcomes for the 5-year follow-up of the Postcards from the EDge project in the future.

Replications of this study and additional effectiveness trials would be necessary before widespread implementation could be considered. The decision to include a subgroup analysis based on gender was a post hoc one based on the findings from the primary outcomes at 12 months. Caution should always be used in interpreting such subgroup analyses because of (unplanned) reduced sample sizes, and judgement needs to be exercised regarding the biological plausibility of such analyses. There may also have been a conservative estimate of treatment effect because 20 persons in the control group were inadvertently exposed to the intervention, whereas 76 persons in the treatment group did not consent to receive the intervention and a further 32 persons were not exposed to the intervention.

Implications of the study

The simple postcard intervention used in this study was previously shown to have nearly halved the number of readmissions for self-poisoning within 12 months: IRR=0.55, 95% CI (0.35-0.87) (Reference Carter, Clover and WhyteCarter et al, 2005). This study of 24-month outcomes showed that this benefit was maintained for a further 12 months after the final contact by postcard: IRR=0.49, 95% CI 0.33–0.73. There were 422 bed-days used by the control group and 183 bed-days used by the postcard group, a total of 239 bed-days saved. This represented a considerable ongoing saving in opportunity costs, availability of hospital beds and decrease in emergency department workload. This low-cost intervention seems to have substantial cost-effectiveness. The simplicity of the intervention means that it could be delivered from hospitals that do not have extensive resources. The difference in total readmissions for self-poisoning came from one main source – women with three or more repeat admissions (see Table 3) – which accounted for a difference of 165 repeat admissions (210 in the control group and 45 in the intervention group).

Benefit of treatment beyond the treatment phase

One other study (n=101) has shown a significant reduction in self-harm over a 24-month period (12 months after treatment cessation): 23% v. 46% (Reference Linehan, Comtois and MurrayLinehan et al, 2006). That study used dialectical behaviour therapy to treat women with recent self-harming behaviour who met criteria for borderline personality disorder. This therapy is an important form of treatment for a subset of patients who self-harm, although it is not applicable universally to the hospital-treated population. One further study (n=44) has shown a sustained reduction in self-mutilation (23% v. 68%) and suicide gesture (18% v. 63%) over 36 months, 18 months after treatment cessation (Reference Bateman and FonagyBateman & Fonagy, 2001). That study used a psychoanalytically informed day hospital programme in patients with borderline personality disorder. Both of these studies suggested that longer-term alternative behaviours to self-harm were learned, such as improvement in coping strategies, emotion regulation, impulse control, self-understanding or relationship quality, which resulted in the maintenance of the beneficial effects (Reference Bateman and FonagyBateman & Fonagy, 2001; Reference Linehan, Comtois and MurrayLinehan et al, 2006). A third study of self-poisoning patients (n=119), using a brief, nurse-led psychological intervention in the patient's home, found the intervention group less likely to report repeated attempts to harm themselves at the 6-month follow-up (9% v. 28%; Reference Guthrie, Kapur and Mackway-JonesGuthrie et al, 2001). Beneficial effects on repetition sustained beyond the duration of the intervention might have been mediated by other beneficial effects on suicidal ideation and treatment satisfaction. All three of these studies used highly selected subgroups within the hospital-treated self-harm population, either people with borderline personality disorder (Reference Bateman and FonagyBateman & Fonagy, 2001; Reference Linehan, Comtois and MurrayLinehan et al, 2006) or a group of only 119 participants from an initial sample of 587 patients presenting with self-poisoning (Reference Guthrie, Kapur and Mackway-JonesGuthrie et al, 2001), which makes comparison with our study more difficult. However, these four studies taken together suggest that if some impact on reduction of repetition of self-harm or self-poisoning behaviour can be made, then perhaps the effects might be sustained over a period beyond that of the intervention.

Although it may also be inferred that some participants in our study learned sustained alternative behaviours to self-poisoning, there was no particular component of the intervention that aimed to induce these specific behavioural changes. The mechanism for the long-term benefits in the Postcards from the EDge study remains speculative. We have planned a qualitative study to explore the question of what mechanisms might have contributed to this. We also do not know whether there was any change in the pattern of psychiatric hospital, psychiatric community service or primary care service use that might have been a mediating factor in the difference in repetition events, but we hope to be able to explore some of these possibilities in the planned 5-year follow-up study.

Comparison with other brief interventions

There are other brief interventions for repetition of hospital-treated self-harm or self-poisoning that can be considered. One of the best-known low-cost interventions for self-harm in the UK was the green card study and the subsequent crisis telephone card study, which showed no difference in the proportion of those repeating self-harm at 6 months (Reference Evans, Morgan and HaywardEvans et al, 1999) or at 12 months (Reference Morgan, Jones and OwenMorgan et al, 1993; Reference Evans, Evans and MorganEvans et al, 2005). The first of these studies (n=212) was underpowered and included only those presenting for the first time with self-harm, who subsequently showed a repeat rate of self-harm of only 8% (Reference Morgan, Jones and OwenMorgan et al, 1993). The second variation (n=827) was adequately powered, used a self-harm case register to define repetition, and found no difference in proportions of those repeating self-harm, with a 12-month repetition rate of 20% (Reference Evans, Evans and MorganEvans et al, 2005). In France, a telephone contact intervention delivered either 1 month or 3 months after an episode of self-poisoning showed no difference in the proportion of a combined ‘adverse effects’ outcome or proportion of self-reported suicide attempt (Reference Vaiva, Ducrocq and MeyerVaiva et al, 2006). That study (n=605) was adequately powered, used a stratified (based on more than four suicide attempts in 3 years), three-arm design and had a 12-month repeat attempted suicide rate of 17%. A multicentre UK study used a manual-assisted cognitive–behavioural therapy intervention for established cases of repeated self-harm and showed no difference in proportion of those with self-reported repeat parasuicide (Reference Tyrer, Thompson and SchmidtTyrer et al, 2003). This study (n=480) was adequately powered (for an expected repetition rate of 45%), used a stratified (based on parasuicide score) design and had a 12-month parasuicide rate of 43%. The comparison condition for these studies was standard treatment or treatment as usual and for the Postcards from the EDge study it was postcards plus treatment as usual v. usual treatment alone. Each of these studies showed a similar non-significant reduction in the proportion of those repeating self-harm (patient rate) of 2.2–7.0% (Reference Crawford and KumarCrawford & Kumar, 2007). However, none of these studies of brief, low-cost interventions analysed the number of episodes of repeated self-harm (event rates) as an outcome, and most used different definitions of the primary outcome and different methods of estimating the rates of that outcome, so comparison with the beneficial finding from the Postcards from the EDge study is difficult despite the similarities of intent underlying the interventions.

Concluding remarks

This study of hospital-treated self-poisoning showed that a low-cost postcard intervention was effective in reducing the number of events per individual by a relative reduction of more than 50%, which was clinically and statistically significant. The postcard intervention continued to be effective in reducing repeat episodes of hospital-treated self-poisoning for 1 year after the intervention ceased.

Acknowledgements

We thank Dr Jerome Motto for his encouragement to use and modify the original intervention for this project. We gratefully acknowledge the contribution of Dr Trish McGettigan, Dr Patrick Oakley, Dr Nav Gupta and Dr Geoff Isbister for patient recruitment and Mr Stuart Allen for data management support. We would also like to thank Professor Bob Goldney and Dr Natalia Carter for alerting us to the Motto study, Mrs Debra Whyte and Mrs Antonia Nash for data entry and Dr Julia Lowe and Dr Dianne O'Connell for schooling us in Zelen designs. Finally, we thank Mrs Helen Rowsell, the departmental secretary, who managed the mailing database and mailing lists so diligently over a long period.

Footnotes

Declaration of interest

None.

References

Bateman, A. & Fonagy, P. (1999) Effectiveness of partial hospitalization in the treatment of borderline personality disorder: a randomized controlled trial. American Journal of Psychiatry, 156, 15631569.Google Scholar
Bateman, A. & Fonagy, P. (2001) Treatment of borderline personality disorder with psychoanalytically oriented partial hospitalization: an 18-month follow-up. American Journal of Psychiatry, 158, 3642.Google Scholar
Brown, G. K., Ten Have, T., Henriques, G. R., et al (2005) Cognitive therapy for the prevention of suicide attempts: a randomized controlled trial. JAMA, 294, 563570.CrossRefGoogle ScholarPubMed
Buckley, N. A., Whyte, I. M., Dawson, A. H., et al (1999) Preformatted admission charts for poisoning admissions facilitate clinical assessment and research. Annals of Emergency Medicine, 34, 476482.CrossRefGoogle ScholarPubMed
Carter, G., Clover, K. & Fryer, J. (1999) Deliberate self-harm: can we move the goal posts closer? eBMJ, http://www.bmj.com/cgi/eletters/317/7156/44 Google Scholar
Carter, G. L., Clover, K., Whyte, I. M., et al (2005) Postcards from the EDge project: randomised controlled trial of an intervention using postcards to reduce repetition of hospital treated deliberate self poisoning. BMJ, 331, 805807.Google Scholar
Crawford, M. J. & Kumar, P. (2007) Intervention following deliberate self-harm: enough evidence to act? Evidence-Based Mental Health, 10, 3739.Google Scholar
Crawford, M. J., Thomas, O., Khan, N., et al (2007) Psychosocial interventions following self-harm: systematic review of their efficacy in preventing suicide. British Journal of Psychiatry, 190, 1117.Google Scholar
Evans, M. O., Morgan, H. G., Hayward, A., et al (1999) Crisis telephone consultation for deliberate self-harm patients: effects on repetition. British Journal of Psychiatry, 175, 2327.Google Scholar
Evans, J., Evans, M., Morgan, H. G., et al (2005) Crisis card following self-harm: 12-month follow-up of a randomised controlled trial. British Journal of Psychiatry, 187, 186187.Google Scholar
Gunnell, D., Bennewith, O., Peters, T. J., et al (2005) The epidemiology and management of self-harm amongst adults in England. Journal of Public Health, 27, 6773.Google Scholar
Guthrie, E., Kapur, N., Mackway-Jones, K., et al (2001) Randomised controlled trial of brief psychological intervention after deliberate self poisoning. BMJ, 323, 135138.CrossRefGoogle ScholarPubMed
House, A., Owens, D. & Patchett, L. (1998) Deliberate self-harm. Effective Health Care, 4, 112.Google Scholar
Linehan, M. M., Armstrong, H. E., Suarez, A., et al (1991) Cognitive-behavioral treatment of chronically parasuicidal borderline patients. Archives of General Psychiatry, 48, 10601064.Google Scholar
Linehan, M. M., Comtois, K. A., Murray, A. M., et al (2006) Two-year randomized controlled trial and follow-up of dialectical behavior therapy vs therapy by experts for suicidal behaviors and borderline personality disorder. Archives of General Psychiatry, 63, 757766.CrossRefGoogle ScholarPubMed
McGrath, J. (1989) A survey of deliberate self-poisoning. Medical Journal of Australia, 150, 317322.Google Scholar
Morgan, H. G., Jones, E. M. & Owen, J. H. (1993) Secondary prevention of non-fatal deliberate self-harm. The green card study. British Journal of Psychiatry, 163, 111112.Google Scholar
Motto, J. A. (1976) Suicide prevention for high-risk persons who refuse treatment. Suicide and Life-Threatening Behavior, 6, 223230.CrossRefGoogle ScholarPubMed
Motto, J. A. & Bostrom, A. G. (2001) A randomized controlled trial of postcrisis suicide prevention. Psychiatric Services, 52, 828833.Google Scholar
Owens, D., Horrocks, J. & House, A. (2002) Fatal and non-fatal repetition of self-harm: systematic review. British Journal of Psychiatry, 181, 193199.CrossRefGoogle ScholarPubMed
Reith, D. M., Whyte, I. M., Carter, G. L., et al (2004) Risk factors for suicide and other deaths following hospital treated self-poisoning in Australia. Australian and New Zealand Journal of Psychiatry, 38, 520525.CrossRefGoogle ScholarPubMed
Tyrer, P., Thompson, S., Schmidt, U., et al (2003) Randomized controlled trial of brief cognitive behaviour therapy versus treatment as usual in recurrent deliberate self-harm: the POPMACT study. Psychological Medicine, 33, 969976.CrossRefGoogle ScholarPubMed
Vaiva, G., Ducrocq, F., Meyer, P., et al (2006) Effect of telephone contacton further suicide attempts in patients discharged from an emergency department: randomised controlled study. BMJ, 332, 12411245.Google Scholar
Whyte, I. M., Dawson, A. H., Buckley, N. A., et al (1997) A model for the management of self-poisoning. Medical Journal of Australia, 167, 142146.CrossRefGoogle Scholar
Whyte, I. M., Buckley, N. A. & Dawson, A. H. (2002) Data collection in clinical toxicology: are there too many variables? Journal of Toxicology – Clinical Toxicology, 40, 223230.Google Scholar
Zelen, M. (1979) A new design for randomized clinical trials. New England Journal of Medicine, 300, 12421245.Google Scholar
Zelen, M. (1990) Randomized consent designs for clinical trials: an update. Statistics in Medicine, 9, 645656.CrossRefGoogle ScholarPubMed
Figure 0

Fig. 1 Study profile (TAU, treatment as usual).

Figure 1

Table 1 Characteristics of the study sample

Figure 2

Fig. 2 Cumulative readmissions to hospital for treatment of self-poisoning (24 months; unadjusted for multiple admissions).

Figure 3

Table 2 Negative binomial models for 24-month outcomes for intervention effect on number of readmissions for self-poisoning and for subgroup analyses by genderNumber of repetitions of self-poisoning by gender and experimental group

Figure 4

Table 3 Number of repetitions of self-poisoning by gender and experimental group

Supplementary material: PDF

Carter et al. supplementary material

Supplementary Material

Download Carter et al. supplementary material(PDF)
PDF 83.4 KB
Supplementary material: File

Carter et al. supplementary material

Supplementary Material

Download Carter et al. supplementary material(File)
File 473 Bytes
Submit a response

eLetters

No eLetters have been published for this article.